Finanzwire Finanzwire
Basculer en Français
9784 Companies
195990 Keywords
127049 Articles
104229 Press releases
Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG Remove
  1. Home
  2. Companies
  3. B.R.A.I.N. Biotechnology Research And Information Network AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/10/2023 at 12:15, 3 years ago

    BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform

    Logo of B.R.A.I.N. Biotechnology Research And Information Network AG
  • PRESS RELEASE

    published on 01/10/2023 at 12:10, 3 years ago

    EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)

    Logo of B.R.A.I.N. Biotechnology Research And Information Network AG
  • PRESS RELEASE

    published on 01/09/2023 at 12:10, 3 years ago

    BRAIN Biotech AG: Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site

    Logo of B.R.A.I.N. Biotechnology Research And Information Network AG
Previous page
1 ... 7 8
Accesswire
  • Published on 02/02/2026 at 15:00, 5 hours 42 minutes ago

    Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform

  • Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago

    Unusual Machines Promotes Drew Camden to President

  • Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago

    Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet

  • Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago

    NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres

  • Published on 02/02/2026 at 14:00, 6 hours 42 minutes ago

    Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio

View all ACCESSWIRE
EQS Group
  • Published on 02/02/2026 at 20:00, 42 minutes ago

    CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy

  • Published on 02/02/2026 at 19:57, 44 minutes ago

    US federal court grants preliminary injunction allowing Sunrise Wind construction to resume

  • Published on 02/02/2026 at 19:42, 59 minutes ago

    EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025

  • Published on 02/02/2026 at 19:05, 1 hour 37 minutes ago

    Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence

  • Published on 02/02/2026 at 18:59, 1 hour 42 minutes ago

    EQS-Adhoc: Deutsche Rohstoff AG: Oil and Gas Reserves increase by 46% – NPV of USD 542 million at USD 60 WTI oil price

View all EQS
Les Echos
  • Published on 02/02/2026 at 18:23, 2 hours 18 minutes ago

    Monthly disclosure of the total number of shares and voting rights - January 2026

  • Published on 02/02/2026 at 18:00, 2 hours 42 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 02/02/2026 at 17:35, 3 hours 7 minutes ago

    Disclosure of transactions in own shares from January 26 to January 30, 2026

  • Published on 02/02/2026 at 17:22, 3 hours 20 minutes ago

    Statement of transactions in own shares from January 26, 2026 to January 30, 2026

  • Published on 02/02/2026 at 08:45, 11 hours 57 minutes ago

    BAIKOWSKI: Business growth in 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy